18F-FDG PET/CT Predicts Response to HER2-directed Neoadjuvant Therapy

Radiol Imaging Cancer. 2021 Sep;3(5):e219021. doi: 10.1148/rycan.2021219021.
No abstract available

Publication types

  • Comment

MeSH terms

  • Fluorodeoxyglucose F18*
  • Neoadjuvant Therapy
  • Positron Emission Tomography Computed Tomography*
  • Positron-Emission Tomography
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18